This episode of DDP TV features Anand Subramony Principal Fellow, Head Novel DDT & Therapeutics Group, Novartis Institutes for BioMedical Research. Subramony sat down to discuss technology methods, trends, and developments, as well as the changing paradigm in the drug delivery industry, the shifting pipeline from small molecules to large molecules. He also weighed in on the future of patient-centric methods, and the future of self-administered medication. View the full interview below.
Targeted drug delivery, Ocular therapy, and transdermal patches have all
been hot topics recently, what other types of trends do you expect to
see for 2014? And how will all these recent developments open doors for
future collaborations?
Want to learn more about the future of drug delivery? IIR's 18th Annual Drug Delivery Partnerships will help you form a drug delivery strategy that keeps you ahead of the market, register today! To learn more, download our agenda.
As a reader of this blog you'll receive $100 off of the standard rate when you use priority code XP1978BLOG to register. We hope to see you January 27-29 in Boca Raton!
No comments:
Post a Comment